tapebrief
WTW · Q4 2025
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

WTW · Q1 2026 Earnings

Willis Towers Watson

Reported April 30, 2026

30-second summary

Organic revenue growth decelerated to 3% in Q1 (from 6% in Q4), and management narrowed the FY2026 R&B framework (driven by CRB) from "mid- to high single-digit" down to "mid-single-digit" while widening Career to "low to mid" — two distinct guide actions in one quarter. Adjusted operating margin of 22.3% held the expansion narrative intact and the FX tailwind was nudged up $0.05 to ~$0.35, but the headline is unambiguous: the FY2026 organic framework just got smaller, and management is leaning on Newfront and FX to hold the EPS picture together.

Headline numbers

EPS

Q1 FY2026

$3.72

Revenue

Q1 FY2026

$2.41B

+8.0% YoY

Free cash flow

Q1 FY2026

$-0.07B

Operating margin

Q1 FY2026

18.6%

Key financials

Q1 FY2026
MetricQ1 FY2026YoYQ4 FY2025QoQ
Revenue$2.41B+8.0%$2.94B-17.8%
EPS$3.72—$8.12-54.2%
Operating margin18.6%—34.6%-1600bps
Free cash flow$-0.07B———

Guidance

Company narrowed full-year organic growth guidance for R&B and CRB segments, offset partially by higher FX tailwind; Career guidance effectively lowered through range expansion.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Career organic revenue growth
FY2026
mid-single-digit growthlow to mid-single-digitRange expanded downward (midpoint lowered from mid-single-digit to low-to-mid)Raised
CRB organic revenue growth
FY2026
mid to high single digit growthmid-single-digitHigh end removed; narrowed from 'mid-to-high' (typically 4-8%) to 'mid-single-digit' (typically 4-6%)Lowered
R&B organic revenue growth
FY2026
mid to high single-digit growthmid-single-digitHigh end removed; narrowed from 'mid-to-high' (typically 4-8%) to 'mid-single-digit' (typically 4-6%)Lowered
Foreign Exchange EPS Benefit
FY2026
~$0.30 tailwind~$0.35 tailwind+$0.05 higher than priorLowered

Segment performance

Q1 FY2026
SegmentQ1 FY2026YoY
Health, Wealth & Career$1.265B+9.0%
Risk & Broking$1.116B+9.0%
HWC Operating Margin27.3%—
R&B Operating Margin22.6%—

Capital & returns

Q1 FY2026
SegmentQ1 FY2026
Share Repurchases$300M

Other KPIs

Q1 FY2026
SegmentQ1 FY2026
Adjusted Operating Margin22.3%
Adjusted EBITDA$589M
Adjusted EBITDA Margin24.4%
Organic Revenue Growth3%
Constant Currency Revenue Growth4%

Management tone

Customer optimization hangover → Specialty growth proof points → Strategic portfolio offense → Defensive guide management

R&B language inverted from confidence to caveat in one quarter. Three months ago, Carl framed R&B as the engine of the FY2026 mid-to-high single-digit framework, with Lucy Clark pointing to specialty wins and high retention as evidence the growth was durable. This quarter Lucy's language is "given the slower start to the year and those ongoing price headwinds, we are taking a prudent approach and narrowing our full year outlook to mid-single digits." The shift signals that the +7% Q4 organic print was not a forward indicator and that the pricing environment management dismissed last quarter is now binding.

Middle East moved from anecdote to outlook driver. Two quarters ago geopolitical risk was a background mention. This quarter it is the explicit justification for the Career guide cut — "with the ongoing uncertainty related to the Middle East conflict, we believe it is prudent to expand our guidance range to low to mid-single-digit growth for the full year for careers" — and the press-release commentary on international new business exposure. Elevating a regional conflict to a segment-level outlook driver is the cleanest signal that management is positioning for an extended slowdown in discretionary advisory work, not a one-quarter air pocket.

"Confidence" replaced "momentum" as the recurring verb. In Q4, management's prepared remarks emphasized momentum, specialty proof points, and structural advantages; this quarter the words "remain confident" appear repeatedly across the qualitative shifts, paired with hedges like "we believe it is prudent," "reflecting the slower start," and "we do not expect a material pickup in the near term." Carl reiterated confidence in delivering on full-year goals despite short-term headwinds, but explicitly conditioned that confidence on macro stabilization. That is a meaningful tonal step down from Q4's unqualified "remain confident in delivering."

AI rhetoric remained intact, but the narrative is now load-bearing. AI and the Newfront platform integration are positioned as the operating leverage that protects margins through an organic slowdown — "Clients are not choosing between human expertise or technology. They expect both." The framing is unchanged from Q4, but with organic decelerating, AI-enabled margin expansion is now the swing factor that makes the FY2026 EPS picture work. If margin expansion disappoints, there is no organic cushion behind it.

"Returned to normalized growth in April" is the tell. The Q1 print was weak enough that management offered an intra-quarter reassurance — "our early view is that we've returned to normalized growth in April" — without quantification. Unquantified post-period commentary in a quarter where guides were cut is a credibility risk; either Q2 confirms the bounce or the FY framework comes down again.

Recurring themes management leaned on this quarter:

AI-enabled efficiency gains and workflow automation as primary margin driverNew Front integration as strategic enabler of end-to-end AI platformSpecialization strategy continuing to resonate despite macro volatilityPricing pressure in large and complex segments offsetting volume gainsGeopolitical uncertainty (Middle East) creating project delays and discretionary spending pullbackStructural advantages (proprietary data, relationships, scale) as durable competitive moat

Risks management surfaced:

Middle East geopolitical conflict causing project deferrals and advisory work slowdownMore competitive pricing environment than expected, particularly in large and complex segmentsEconomic uncertainty and caution impacting discretionary spending decisions by clientsMacro volatility affecting visibility and timing of new business conversionForeign exchange headwinds (though partially benefiting current quarter)

Answers to last quarter's watch list

Q1 FY2026 organic growth and whether the FX tailwind flatters reported EPS in line with management's framing — Q1 organic came in at 3% (vs. the mid-single-digit FY framework), with reported revenue +8% YoY and constant-currency +4%. The 5pt gap between reported and organic is materially wider than at any point in FY2025, confirming that FX is doing the lifting on the headline. FX tailwind was also nudged up to ~$0.35 from ~$0.30, suggesting the H1-weighting management flagged in Q4 is materializing.
Resolved negatively
Newfront close timing and whether the ~$250M revenue / ~26% EBITDA margin / $0.10 dilution framework holds — The framework was reaffirmed verbatim (~$250M post-close revenue at ~26% adjusted EBITDA margin, ~$0.10 dilutive). The company did not disclose updated close timing in the press release.
Continue monitoring
Willis Re JV launch progress and whether the $0.30 FY2026 EPS headwind drifts — Reaffirmed at ~$0.30 headwind with no change. No update on market entry timing.
Resolved positively
Whether R&B sustains organic growth in the mid-to-high single digits or whether the +7% Q4 organic print decelerates — R&B Q1 organic came in at 2%, and the FY guide was narrowed from "mid- to high single-digit" to "mid-single-digit" in the same print, removing the high end of the prior range. The +7% Q4 organic did not extend.
Resolved negatively
ICT trajectory in H1 FY2026 — ICT delivered 5% organic in Q1, its strongest performance in several quarters, driven by technology sales. FY guide reaffirmed at low- to mid-single-digit.
Resolved positively
Buyback cadence in Q1/Q2 — $300M repurchased in Q1, which is a 30% pace against the ≥$1.0B FY floor. Pacing supports clearing the floor but is well below the FY2025 actual cadence.
Continue monitoring
Q1 HWC organic growth as the TRANZACT lap completes — HWC organic growth was 3%, in line with the mid-single-digit FY framework; the Career sub-segment was narrowed downward while health (+6%) and wealth (+4%) carried the composite.
Resolved positively

What to watch into next quarter

Whether Q2 organic growth recovers above 4% to validate management's "returned to normalized growth in April" claim — Q2 prior-year revenue base was $2.26B (Q2 FY2025), and the mid-single-digit FY guide implies Q2 organic needs to step back toward 5%+ to hold the FY framework.

Whether R&B organic in Q2 lands in mid-single-digit range as guided, or whether the slowdown deepens and forces a second cut to the FY framework.

CRB Q2 organic specifically — the narrowing was driven by pricing pressure in large/complex segments, and any further deceleration here would put the R&B composite at risk.

Middle East commentary in Q2: whether project deferrals are confirmed as recovering, holding flat, or extending — a second quarter of regional-risk language would suggest the Career guide cut is structural rather than cyclical.

Q2 adjusted operating margin against the ~100bps R&B expansion guide — with organic growth narrowing, the operating-leverage math gets tighter, and any margin softness would expose the structural cost-out narrative.

Newfront close progress and whether the ~$250M / ~26% EBITDA framework gets refined as integration disclosure begins.

Q2 buyback pace — $300M in Q1 implies ~$700M needed across Q2–Q4 to hit the floor; any further deceleration would suggest cash is being held for M&A or to defend the FCF margin guide.

Sources

  1. WTW Q1 FY2026 press release (Exhibit 99.1), SEC EDGAR filing dated 2026-04-30: https://www.sec.gov/Archives/edgar/data/1140536/000117184326002866/exh_991.htm
  2. WTW Q1 FY2026 earnings call prepared remarks and Q&A (Greenspan/Wells Fargo and Cox/Goldman Sachs exchanges)
  3. WTW Q4 FY2025 Tapebrief (internal, for FY2026 framework baseline and watch-list resolution)
  4. WTW Q3 FY2025 Tapebrief (internal, for multi-quarter R&B and tone arc)
  5. WTW Q2 FY2025 Tapebrief (internal, for multi-quarter tone arc)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.